Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Disordered proteins in dementia.

Martin Ingelsson1, Bradley T Hyman

  • 1Harvard Medical School, Massachusetts General Hospital, Charlestown 02129, USA.

Annals of Medicine
|October 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reconstitution of the Alzheimer's Disease Tau Core Structure from Recombinant Tau<sup>297-391</sup> Yields Variable Quaternary Structures as Seen by Negative Stain and Cryo-EM.

Biochemistry·2023
Same author

Aberrant vascular architecture in the hippocampus correlates with tau burden in mild cognitive impairment and Alzheimer's disease.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2023
Same author

Cases of familial idiopathic normal pressure hydrocephalus implicate genetic factors in disease pathogenesis.

Cerebral cortex (New York, N.Y. : 1991)·2023
Same author

Reply: Soluble oligomers or insoluble fibrils?

Acta neuropathologica·2023
Same author

Age-Dependent Increase in Tau Phosphorylation at Serine 396 in Huntington's Disease Prefrontal Cortex.

Journal of Huntington's disease·2023
Same author

APOE2 gene therapy reduces amyloid deposition, and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease.

bioRxiv : the preprint server for biology·2023
Same journal

Association of neutrophil percentage-to-albumin ratio with sepsis in infant.

Annals of medicine·2026
Same journal

Enhancing Hemoglobin Bart's hydrops fetalis syndrome prevention: a single-tube multiplex real-time PCR assay for the comprehensive detection of four significant α<sup>0</sup>-thalassemia deletions (--<sup>SEA</sup>, --<sup>THAI</sup>, --<sup>CR</sup>, and --<sup>SA</sup>) found in Thailand.

Annals of medicine·2026
Same journal

Association of non-insulin-based insulin resistance indices with the risk of aortic stenosis progression in patients with mild or moderate aortic stenosis.

Annals of medicine·2026
Same journal

Transcutaneous auricular vagus nerve stimulation combined with ciprofol for sedation in patients undergoing same-session bidirectional endoscopy: a randomized, double-blind, placebo-controlled, three-arm non-inferiority trial protocol.

Annals of medicine·2026
Same journal

Combined allogeneic osteochondral mosaicplasty and high tibial osteotomy for severe talus osteochondral lesions (Hepple Type V): clinical efficacy, inflammatory response and prognostic factors.

Annals of medicine·2026
Same journal

Early metabolic trajectory and sedation strategy in V-V ECMO for severe pneumonia: a multicenter cohort study.

Annals of medicine·2026
See all related articles

Protein aggregates in brain neurons are hallmarks of dementia, driving disease development. Understanding these mechanisms offers new therapeutic strategies for neurodegenerative disorders.

Area of Science:

  • Neuroscience
  • Neuropathology
  • Molecular Biology

Background:

  • Protein and peptide aggregates in brain neurons are central to dementia's pathology.
  • These aggregates are implicated as direct causes of neurodegenerative diseases.
  • Genetic discoveries have elucidated protein dysregulation mechanisms in Alzheimer's, frontotemporal dementia, and prion diseases.

Purpose of the Study:

  • To summarize the current understanding of protein aggregation in dementia.
  • To highlight the role of genetic discoveries in characterizing disease mechanisms.
  • To identify potential therapeutic avenues based on molecular insights.

Main Methods:

  • Review of neuropathological features of dementia.
  • Analysis of genetic factors in inherited dementia forms.

Related Experiment Videos

  • Synthesis of current knowledge on protein dysregulation mechanisms.

    • Main Results:

    • Protein aggregates are key neuropathological hallmarks of dementia.
    • Gene discoveries have significantly advanced understanding of disease mechanisms.
    • No efficient pharmacotherapies currently exist for these disorders.

    Conclusions:

    • Dysfunctional protein aggregation is a critical factor in dementia.
    • Insights into molecular mechanisms provide a basis for developing novel therapies.
    • Future strategies aim to prevent or cure devastating dementing disorders.